American Healthcare REIT, Inc. (NYSE:AHR) Short Interest Update

American Healthcare REIT, Inc. (NYSE:AHR - Get Free Report) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,370,000 shares, a drop of 16.9% from the February 28th total of 7,670,000 shares. Approximately 4.1% of the company's stock are sold short. Based on an average daily trading volume, of 1,850,000 shares, the short-interest ratio is currently 3.4 days.

American Healthcare REIT Stock Performance

Shares of AHR stock traded down $1.91 during midday trading on Friday, hitting $28.49. The company had a trading volume of 2,545,126 shares, compared to its average volume of 1,732,308. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37. The company's 50 day simple moving average is $29.18 and its 200 day simple moving average is $27.80. American Healthcare REIT has a 52-week low of $12.81 and a 52-week high of $31.61. The stock has a market cap of $4.49 billion, a price-to-earnings ratio of -59.35, a PEG ratio of 1.57 and a beta of 1.42.

American Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.51%. American Healthcare REIT's dividend payout ratio (DPR) is -370.37%.

Wall Street Analyst Weigh In

AHR has been the topic of several research analyst reports. Royal Bank of Canada reissued an "outperform" rating and set a $34.00 target price on shares of American Healthcare REIT in a research report on Wednesday, March 19th. KeyCorp dropped their target price on shares of American Healthcare REIT from $35.00 to $34.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Morgan Stanley boosted their price target on shares of American Healthcare REIT from $36.00 to $37.00 and gave the company an "overweight" rating in a research report on Tuesday, March 25th. JMP Securities set a $35.00 target price on American Healthcare REIT in a report on Tuesday, March 4th. Finally, Citigroup reaffirmed an "outperform" rating on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Seven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $33.33.

Remove Ads

Institutional Investors Weigh In On American Healthcare REIT

Hedge funds have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its stake in shares of American Healthcare REIT by 189.0% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock worth $29,000 after buying an additional 633 shares in the last quarter. GAMMA Investing LLC lifted its holdings in American Healthcare REIT by 104.1% in the fourth quarter. GAMMA Investing LLC now owns 988 shares of the company's stock valued at $28,000 after acquiring an additional 504 shares during the period. Richardson Capital Management LLC purchased a new stake in shares of American Healthcare REIT during the 4th quarter worth $29,000. Carolina Wealth Advisors LLC purchased a new position in shares of American Healthcare REIT in the 4th quarter valued at about $29,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in American Healthcare REIT during the third quarter worth about $28,000. Institutional investors and hedge funds own 16.68% of the company's stock.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.